Fundz

PathAI

Boston, Massachusetts, United States · Artificial Intelligence, Biotechnology, Health Care

PathAI is the only AI-focused technology company to provide comprehensive precision pathology solutions from wet lab services to algorithm deployment for clinical trials and diagnostic use. Rigorously trained and validated with data from more than 15 million annotations, its AI-powered models can be leveraged to optimize the analysis of patient samples to improve efficiency and accuracy of patholo

You have opened 5 full company profiles today. Create an account to keep reading them. Create an account

Key facts

Headquarters
Boston, Massachusetts, United States
Employees
280
Industries
Artificial Intelligence, Biotechnology, Health Care
Status
Private
Website
pathai.com
LinkedIn
Company page

Recent activity at PathAI

Employee benefit plans

PathAI files 2 employee benefit plans with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.

About PathAI: questions and answers

What does PathAI do?

PathAI is the only AI-focused technology company to provide comprehensive precision pathology solutions from wet lab services to algorithm deployment for clinical trials and diagnostic use. Rigorously trained and validated with data from more than 15 million annotations, its AI-powered models can be leveraged to optimize the analysis of patient samples to improve efficiency and accuracy of patholo

Where is PathAI headquartered?

PathAI is headquartered in Boston, Massachusetts, United States.

How many employees does PathAI have?

PathAI has about 280 employees.

What is the latest news on PathAI?

On Jan 23, 2025, PathAI Partners with Discovery Life Sciences to Deploy AI-Powered Biospecimen Solutions

Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy

Fundz watches PathAI across 18 signal types, from funding and M&A to exec moves and hiring.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.